Galenisys Newsletter : February 2026 Table of Contents * TALES FROM FARAWAY PHARMA by Steve Biddulph * LETS BE CLEAR SEEING THROUGH THE FOG by The Editor * "GENERATION Z", AND FUTURE HEALTH by Hannah Westwood * THE WAR GOES ON by The Editor * DOWNSIZING WITH ELI LILLY AND NOVO NORDISK by The
Galenisys Newsletter : January 2026 Table of Contents * TALES FROM FARAWAY PHARMA India & an Unqualified Success By Steve Biddulph * SUCCESSFUL PARTNERING WITH ASIAN COMPANIES Plenty of due diligence necessary By Richard van Duyse * PHARMA FASHION Where will the GLP 1s take us By The Editor * THE FAMILY ENVIRONMENT Christmas in
Galenisys Newsletter : December 2025 Table of Contents * TALES FROM FARAWAY PHARMA By Steve Biddulph * WHAT PANDEMIC ? By The Editor * VALIDATION, WHOSE BABY IS IT! By Bill Torpey * WHICH STANDARDS DO YOU HAVE? By The Editor * EASY COME – EASY GO By The Editor TALES FROM FARAWAY PHARMA by Steve Biddulph Fellow
Galenisys Newsletter : November 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA COLUMBIA: THE SEEN & UNSEEN RISKS By Steve Biddulph * SHRIMPS, ALIENS, AND HEALTH SECRETARIES By The Editor * CHECK THAT FAT! Small problems can cause big delays By Bill Torpey * TYLENOL AND SMARTIES The President’s
Galenisys Newsletter : October 2025 Table of Contents By Tony Dunford Editor * CLOSE SHAVES & COMPANY EXISTENCE By Bill Torpey * Wrong again, Mr Secretary! Robert F Kennedy Junior creates another headache. By The Editor * TALES FROM FARAWAY PHARMA My rumble in the jungle By Steve Biddulph * THE RETURN OF THE VIRUS.
Galenisys Newsletter : September 2025 Table of Contents By Tony Dunford Editor * WELCOME BACK, WE ARE READY TO GET STUCK IN! Steve Biddulph * TALES FROM FARAWAY PHARMA Weird situations crop up even in our industry. By AUBONNE * WATER IS SO IMPORTANT IN THE PHARMA INDUSTRY Like freedom – eternal vigilance is required
Galenisys Newsletter : August 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA “Dangerous Questions” By Steve Biddulph * THE PHARMA TARIFF TIDE The Editor * THE VALUABLE PROCESS OF FREEZE DRYING By Richard van Duyse * VACCINES, GOOD & BAD NEWS By The Editor TALES FROM FARAWAY PHARMA By Steve
Galenisys Newsletter : July 2025 Table of Contents By Tony Dunford Editor * TALES FROM FARAWAY PHARMA Part 1 Dress Code Ecuador. By Steve Biddulph * COMBATING FAKE MEDICINE By Richard van Duyse * OUT OF TOUCH, OUT OF POCKET! “If you want to influence events, be there” By The Editor * A GOOD READ
Galenisys Newsletter : June 2025 Table of Contents By Tony Dunford Editor * The President vs. Big Pharma (as of mid-May!) By the Editor * FACING DISASTER: Knowledge and Experience Count By Bill Torpey * Due Diligence versus Audit/Inspection By Richard van Duyse * Flying blind? Less tracking and forecasting. The Editor The President
Table of Contents By Tony Dunford Editor * PHARMA INVESTMENT. WHAT DOES IT TAKE? By the Editor * THE PROJECT MANAGERS NOTEBOOK part 10 The final article & summary on managing a pharma project. By “Aubonne” * KNOWING THE BUSINESS and GETTING INTO THE ESSENTIALS By Bill Torpey * ESTABLISHING AFRICAN VACCINE MANUFACTURING Part
Table of Contents By Tony Dunford Editor * THE TOUGHEST EPIDEMIC EVER AT US CENTERS OF DISEASE CONTROL? By the Editor * ESTABLISHING AFRICAN VACCINE MANUFACTURING Part 1 By Richard van Duyse * THE PROJECT MANAGERS NOTEBOOK part 9 By “Aubonne” * NON CONFORMATIES: LIFE SCIENCES CONTINUING PROBLEM The second in a new series
Table of Contents By Tony Dunford Editor * The Professor, AI, and superbugs By the Editor * VACCINE MANUFACTURE IN AFRICA – PROGRESS & CHALLENGES By Richard van Duyse * THE PROJECT MANAGERS NOTEBOOK part 8 By “Aubonne” * CHANGE CONTROL The second in a new series of articles on complex areas of QA, tools